{"id":56884,"date":"2021-03-04T09:32:48","date_gmt":"2021-03-04T08:32:48","guid":{"rendered":"https:\/\/www.fedaiisf.it\/?p=56884"},"modified":"2021-03-04T10:54:49","modified_gmt":"2021-03-04T09:54:49","slug":"emendamento-castello-pirro-ritirato-anche-il-3-0-9-bis-al-momento-della-votazione","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/emendamento-castello-pirro-ritirato-anche-il-3-0-9-bis-al-momento-della-votazione\/","title":{"rendered":"Castellone Pirro amendment. 3.0.9 bis was also withdrawn at the time of the vote"},"content":{"rendered":"

At first, Senators Castellone and Pirro had presented the amendment 3.0.9 to the law of "Conversion into law of the decree-law of 14 January 2021, n. 2\u201d in which the scientific informants were inserted \"\"of the drug among the categories to be vaccinated as a priority.<\/p>\n

This first amendment was then withdrawn and replaced by 3.0.9 bis in which, in addition to the ISFs, product and device specialists were also included.<\/p>\n

Yesterday, March 3, at the time of the vote in the Chamber, this too was withdrawn<\/p>\n

\"\"<\/p>\n

At the end of the discussion, the President of the session called the nominal vote with simultaneous scrutiny of the bill, consisting of only article 1, in the amended text, with the following title: \u00abConversion into law, with modifications, of the decree-law of 14 January 2021, no. 2, containing further urgent provisions on the containment and prevention of the epidemiological emergency from COVID-19 and on the holding of elections for the year 2021".<\/p>\n

(Voting follows).<\/i><\/p>\n

\"\"<\/p>\n

 <\/p>\n

Shorthand report<\/a><\/p>\n

Related news:\u00a0The Castellone Pirro amendment is being discussed in the Senate: ISF must be included in the priority categories<\/a><\/p>","protected":false},"excerpt":{"rendered":"

In un primo momento le Senatrici Castellone e Pirro avevano presentato l\u2019emendamento 3.0.9 alla legge di “Conversione in legge del decreto-legge 14 gennaio 2021, n. 2” in cui venivano inseriti gli informatori scientifici del farmaco fra le categorie da vaccinare prioritariamente. Questo primo emendamento veniva poi ritirato sostituito dal 3.0.9 bis in cui, oltre agli …<\/p>","protected":false},"author":4,"featured_media":56889,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[39],"class_list":["post-56884","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-vaccini"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/56884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=56884"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/56884\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/56889"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=56884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=56884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=56884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}